000			09374nam a2200445Ia 4500
003			OSt
005			20260729153149.0
008			2310s2022 ua a frm 000 engnd d
040			_aEG-EULC _beng _cEG-EULC _dEG-EULC _erda
041	0		_aeng _beng _bara
049			_aDeposit
082			_a616.99424
092			_a616.99424 _221
097			_aPh.D
099			_aCai01.12.04.Ph.D.2022.Ch.S
100			_aChaymaa Ahmed Mohamed Abdullah, _epreparation.
245			_aStudying the Accuracy of TreatmentPlanning Calculations / _c by Chaymaa Ahmed Mohamed Abdullah ; Supervisors Prof.Dr.Osiris Wanis Guirguis, Wael Helmy Elsheshtawy, Prof.Dr.Hamed Ibrahim Farag, Prof.Dr.Hassan Shafeik Ali Abou-Elenein.
246			_aدراسة دقة حساباث التخطيط العلاجى
264		0	_c2022.
300			_a132 p. : _billustrations ; _c25cm+ _eCD
336			_2rda content _atext
337			_2rdamedia _aUnmediated
338			_2rdacarrier _avolume
502			_aThesis (Ph.D)-Cairo University,2022.
504			_aBibliography: p. 129-109.
520		3	_aThe dosimetric effect due to the presence of air cavity is one of the major concerns for lung cases. When tumors are near air cavities or low density material such as lung are treated with photon beam energy, the surface layers located beyond the low density/tissue interface are under-dosed due to a loss of both lateral and longitudinal electronic equilibrium. Although the Anisotropic Analytical Algorithm (AAA) is more widely used in clinical practice, Acuros XB (AXB) has been found to be more accurately calculate the dose distribution in heterogeneous media. Prediction of clinical outcomes should be based on dose calculation modeling to the patient as accurately as possible. To evaluate that one algorithm is more accurate than the other require knowledge about the actual absorbed dose in case of extreme heterogeneity. The aim of the present study was to investigate the dosimetric performance of Anisotropic Analytical Algorithm (AAA) and Acuros XB (AXB). Also, to evaluate their accuracy in clinical plans of Intensity Modulated Radiation Therapy (IMRT) technique for patients with locally advanced Non-Small Cell Lung Cancer (NSCLC). A heterogeneous phantom to investigate the dose prediction accuracy of AXB and AAA beyond low-density medium by comparing the calculated results with the measurements was used. Also, a special phantom analogous to a lung cancer patient was designed for this study to view the dose distribution inside and around a tumor inside lung tissue using both the Radiochromic EBT-2 films and Thermoluminescent dosimeters (TLDs). Isodose comparison and 2D gamma analysis were used to quantify the agreement between the film measurements and the calculated dose distributions from both AXB and AAA. The algorithms were evaluated for clinical practice as the study included 32 patients with locally advanced NSCLC were subjected to radiation therapy with IMRT technique. The dose regimen was 60 Gy over 30 fractions. The effects on Planning Target Volume (PTV) and Organ At Risk (OAR) were evaluated using AXB and AAA inpatient’s plans to compare the accuracy of the calculation. Clinically acceptable treatment plans with AAA were re-calculated using AXB algorithm with the two modes of calculation Dose to water (Dw) and Dose to medium (Dm) at the same beam arrangements and multileaf collimator leaf settings as with AAA. The heterogonous phantom study showed that the results of AXB had better agreement with the measurements than AAA and the average dose difference for all points was about 0.5%. Conversely, AAA showed a lower agreement with measured values and the average difference was up to 5.9%. The results of TLDs and films in lung phantom showed that the dose agreement of AXB was within 3% of doses measured with TLD for all measurement points and that gamma analysis of the film measurements passed the ±3%/3 mm criteria with 97.5% passing rate, while, AAA tends to overestimate the dose over both TLDs and films and had a lower agreement. For the clinical cases, the mean differences observed between the AAA, AXB_Dm, and AXB_Dw were statistically significant (p < 0.05), for most of the parameters evaluated. The maximum relative difference was between AXB_Dm and AAA for PTV dose (D98%).Also the percentage dose differences of plans calculated by AAA, AXB_Dw and AAA, AXB_Dm revealed AAA overestimated the dose than AXB. Regarding Organs At Risk (OAR), results showed significant difference between both AAA and AXB_Dw, AAA and AXB_Dm for lungs-PTV as AAA showed higher mean dose, higher V5, V10 and V20 when compared to both AXB modes with p values 0.0001, 0.0001, 0.0001 and 0.0001, respectively. Heart evaluation showed significantly higher mean dose in AAA algorithm with p value 0.0001 in comparison with both AXB modes, however, there was a significant higher difference between AXB_Dw and AAA in terms of V40 and a non-significant difference for V45 with P values 0.02 and 0.22, respectively. Statistical significance of the maximum dose differences between the AXB_Dw, AXB_Dm and AAA plans was observed for the spinal cord (P = 0.0001), but not for esophagus (p = 0.04 and 0.26). Moreover, mean dose of esophagus was also non significantly in AAA algorithm compared with AXB_Dw (p = 0.17), while for AAA with AXB_Dm there was a significant difference (p = 0.0001). Acuros XB algorithm has accurate dose prediction in heterogeneous medium in comparison to AAA. Differences in dose distribution were observed when plans re-calculated with AXB indicating AAA apparently overestimates dose, particularly the PTV dose. AXB principally predicts lower dose in case of tissue heterogeneity compared to AAA. The AXB algorithm should be used in preference to AAA for cases in which PTVs are involved with tissues of highly different densities, such as lung.
520		3	_aيعد تأثير قياس الجرعات بسبب وجود تجويف الهواء أحد الاهتمامات الرئيسية لحالات الرئة. عندما تكون الأورام بالقرب من تجاويف الهواء أو المواد منخفضة الكثافة مثل الرئة يتم علاجها باستخدام طاقة شعاع الفوتون ، فإن الطبقات السطحية الموجودة خارج واجهة الكثافة / الأنسجة منخفضة الجرعة بسبب فقدان كل من التوازن الإلكتروني الجانبي والطولي. على الرغم من أن الخوارزمية التحليلية متباينة الخواص (AAA) تستخدم على نطاق واسع في الممارسة السريرية ، فقد وجد أن Acuros XB (AXB) أكثر دقة في حساب توزيع الجرعة في الوسائط غير المتجانسة. يجب أن يعتمد التنبؤ بالنتائج السريرية على نمذجة حساب الجرعة للمريض بأكبر قدر ممكن من الدقة. لتقييم أن إحدى الخوارزميات أكثر دقة من الأخرى ، يتطلب الأمر معرفة الجرعة الممتصة الفعلية في حالة عدم التجانس الشديد. كان الهدف من هذه الدراسة هو التحقق من أداء قياس الجرعات للخوارزمية التحليلية متباينة الخواص (AAA) و Acuros XB (AXB). أيضًا ، لتقييم دقتها في الخطط السريرية لتقنية العلاج الإشعاعي المعدل الكثافة (IMRT) للمرضى الذين يعانون من سرطان الرئة ذو الخلايا غير الصغيرة المتقدم محليًا (NSCLC). تم استخدام شبح غير متجانس للتحقيق في دقة التنبؤ بالجرعة لـ AXB و AAA خارج الوسط منخفض الكثافة عن طريق مقارنة النتائج المحسوبة مع القياسات. أيضًا ، تم تصميم شبح خاص مشابه لمريض سرطان الرئة لهذه الدراسة لعرض توزيع الجرعة داخل وحول الورم داخل أنسجة الرئة باستخدام كل من أفلام Radiochromic EBT-2 ومقاييس الجرعات الحرارية (TLDs). تم استخدام مقارنة جرعة متساوية وتحليل جاما ثنائي الأبعاد لتحديد الاتفاق بين قياسات الفيلم وتوزيعات الجرعة المحسوبة من كل من AXB و AAA. تم تقييم الخوارزميات من أجل الممارسة السريرية حيث اشتملت الدراسة على 32 مريضاً مصابين بمرض NSCLC المتقدم محلياً
530			_aIssues also as CD.
546			_aText in English and abstract in Arabic & English.
650		1	_aLung tumors
653		0	_aTreatment Planning System (TPS)
700			_aOsiris Wanis Guirguis _ethesis advisor.
700			_aWael Helmy Elsheshtaw _ethesis advisor.
700			_aHamed Ibrahim Farag _ethesis advisor.
700			_aHassan Shafeik Ali Abou-Elenein. _ethesis advisor.
900			_b01-01-2022 _cOsiris Wanis Guirguis _cWael Helmy Elsheshtawy _cHamed Ibrahim Farag _cHassan Shafeik Ali Abou-Elenein _UCairo University _FFaculty of Science _DDepartment Biophysics
905			_aShimaa
942			_cTH _2ddc
999			_c164270